Riskpilot← Back to searchSign inGet full accessVimixor AB
ABActiveOrg 5568230949HelsingborgOther financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20101-4 employees
Revenue 2025
SEK 0
EBITDA margin
—
-64% vs 2024
Equity ratio
99.4%
Financial strength
Net profit 2025
SEK 123,1M
+5206% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -305K | -64% |
| Net profit | SEK 123,1M | +5206% |
| Total assets | SEK 223,7M | +120% |
| Equity | SEK 222,4M | +121% |
| Employees | — | — |
Legal name
Vimixor AB
Org number
5568230949
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
1 november 2010
Share capital
SEK 50 000
Employees
1-4
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva försäljning av läkemedel, läkemedelsnära produkter och annan därmed förenlig verksamhet. Konsultverksamhet inom ovan nämnda områden. Bolaget skall även bedriva handel med värdepapper samt därmed förenlig verksamhet. Bolaget skall dessutom förvalta fast egendom samt därmed förenlig verksamhet.
Address
Helsingborg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −453 | 6 596 | −33 | −53 | −152 | −168 | −150 | −181 | −186 | −305 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −453 | 6 596 | −33 | −53 | −152 | −168 | −150 | −181 | −186 | −305 |
| Net financials | 43 829 | 130 | −32 | 112 | 25 | 228 | 690 | 2 326 | 2 869 | 123 452 |
| Profit before tax | 43 376 | 6 725 | −65 | 58 | −126 | 59 | 540 | 2 146 | 3 030 | 123 694 |
| Tax | −30 | −2 489 | −29 | −20 | −0 | −36 | −132 | −366 | −711 | −642 |
| Net profit | 43 346 | 4 236 | −94 | 38 | −126 | 23 | 408 | 1 780 | 2 319 | 123 052 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 135 357 | 141 191 | 140 924 | 138 289 | 137 964 | 137 553 | 97 533 | 99 642 | 101 540 | 223 719 |
| Equity | 134 549 | 138 635 | 138 372 | 138 240 | 137 944 | 137 517 | 97 365 | 99 145 | 100 463 | 222 365 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 808 | 2 556 | 2 552 | 49 | 20 | 36 | 168 | 498 | 1 077 | 1 354 |
| Total debt | 808 | 2 556 | 2 552 | 49 | 20 | 36 | 168 | 498 | 1 077 | 1 354 |
EBITDA margin
-30500000.0%
This company
15.8%
Market median
-193038075% vs market
20162025
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
20162025
Return on equity
55.3%
This company
18.4%
Market median
+201% vs market
20162025
Net profit margin
12305200000.0%
This company
8.1%
Market median
+151916049283% vs market
20162025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-05-01 – 2016-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DA | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vimixor AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Andreas Johansson | Audit | 0 companies |
| Malin Susanne Tapper | Deputy Board Member | 0 companies |
| Roger Carl-Gunnar Tapper | Board of Directors | 0 companies |